Order results by:
| Issue | Title | |
| Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
| D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
| "... of patients with MCI on a background of CVD and NDD. Further studies on inhaled nitric oxide therapy ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... diseases. Objective: to investigate the use of inhaled nitric oxide (Tianox device) in patients with MCI ..." | ||
| Vol 5, No 1 (2013) | Mild and moderate cognitive impairments: clinical manifestations, etiology, pathogenesis, treatment approaches | Abstract similar documents |
| Irina Sergeyevna Preobrazhenskaya | ||
| "... of moderate cognitive impairments (MCI). Criteria for the diagnosis of MCI are considered in detail ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... The development of dementia is preceded by mild cognitive impairment (MCI), the treatment of which ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... . For several years before dementia develops, it is often preceded by mild cognitive impairment (MCI), which ..." | ||
| Vol 11, No 2 (2019) | Comparative study of pharmacological correction strategies for moderate cognitive impairment in hypertensive patients | Abstract similar documents |
| O. V. Vorobyeva, Zh. M. Sizova, L. M. Bogatyreva | ||
| "... a naturalistic comparative study of the efficiency of various therapeutic strategies for moderate CI (MCI ..." | ||
| Vol 9, No 2 (2017) | Cognitive impairment without dementia: A current view of the problem | Abstract similar documents |
| Yu. A. Starchina | ||
| "... , which include moderate (MCI), mild, and subjective ones. Epidemiological studies suggest ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... A common tool for detecting mild cognitive impairment (MCI) is the Montreal Cognitive Assessment ..." | ||
| Vol 1, No 2 (2009) | DIAGNOSIS AND TREATMENT OF MODERATE COGNITIVE IMPAIRMENT | Abstract similar documents |
| V. V. Zakharov | ||
| "... . The paper describes diagnostic criteria for moderate cognitive impairment (MCI), its epidemiology, etiology ..." | ||
| Vol 8, No 3 (2016) | EEG markers of cognitive impairments in patients with coronary artery disease | Abstract similar documents |
| I. V. Tarasova, I. N. Kukhareva, O. L. Barbarash | ||
| "... cognitive impairments (MCI), their average Mini-Mental State Examination (MMSE) score was 26.2±0 ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... and treatment of mild cognitive impairment (MCI) syndrome. It is demonstrated that the nosological structure ..." | ||
| Vol 5, No 4 (2013) | Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments | Abstract similar documents |
| Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova | ||
| "... The article presents data on different forms of moderate cognitive impairments (MCI ..." | ||
| Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
| "... of individuals with mild CI (MCI) lies in the fact that timely diagnosis of these disorders increases ..." | ||
| Vol 13, No 3 (2021) | Heterogeneity of the mild cognitive impairment syndrome (specialized outpatient service data analysis) | Abstract similar documents |
| A. B. Lokshina, V. V. Zakharov, D. A. Grishina, N. N. Koberskaya, E. A. Mkhitaryan, S. I. Posohov, N. N. Yakhno | ||
| "... the features of mild CI (MCI) syndrome in patients with neurological disorders based on the specialized ..." | ||
| Vol 11, No 4 (2019) | Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk | Abstract similar documents |
| V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik | ||
| "... .9%) patients. Moderate CI (MCI) was found in 40 (36.1%) patients. The follow-up duration was 24.6 (14.4–34 ..." | ||
| Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
| G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
| "... . Moderate CIs (MCIs) occur in 18.9–55% of patients with PD; the prevalence of dementia during a cross ..." | ||
| Online-first | Прогностическая значимость умеренных когнитивных нарушений у пациентов с высоким и очень высоким кардиоваскулярным риском | Abstract similar documents |
| В. В. Генкель, А. С. Кузнецова, А. О. Салашенко, Е. В. Лебедев, И. И. Шапошник | ||
| "... (63,9%) patients scored ≥28 points on the MMSE scale. Mild cognitive impairment (MCI) were detected ..." | ||
| Vol 17, No 1 (2025) | Subjective and functional cognitive impairment: diagnostics using biological markers of Alzheimer's disease | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Zakharov, K. V. Shevtsova, Ya. I. Chervyakova | ||
| "... of dementia is usually preceded by subjective (SCI) and mild cognitive impairment (MCI) over several years ..." | ||
| Vol 9, No 4 (2017) | Membrane characteristics and vascular cognitive impairment | Abstract PDF (Eng) similar documents |
| Yu. V. Zhitkova, D. R. Khasanova, V. N. Oslopov | ||
| "... impairment (MCI). Different types of MCI were observed to be transformed to the prognostically unfavorable ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... ) with a typical picture of AD [30 patients in the moderate cognitive impairment (MCI) stage and 33 in the mild ..." | ||
| Vol 15, No 1 (2023) | Modern aspects of diagnosis and treatment of cognitive impairments (literature review) | Abstract similar documents |
| A. B. Lokshina, V. V. Zakharov, N. V. Vakhnina | ||
| "... variants of diseases with MCI syndrome and dementia of varying severity are presented. ..." | ||
| Vol 14, No 6 (2022) | Cognitive impairment and small vessel disease in atrial fibrillation | Abstract similar documents |
| P. M. Krupenin, O. N. Voskresenskaya, D. A. Napalkov, A. A. Sokolova | ||
| "... of mild cognitive impairment (MCI) and cerebral small vessel disease. Patients and methods. The study ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... impairment (MCI) developed in a background of arterial hypertension and cerebral arteriosclerosis. Material ..." | ||
| Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
| V. A. Parfenov | ||
| "... of coronavirus infection are discussed. A wide prevalence of patients with mild CI (MCI), an important role ..." | ||
| Vol 16, No 6 (2024) | Vitamins and other nutrients that support nitric oxide homeostasis and counteract the development of endotheliopathy | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, L. A. Mayorova | ||
| "... Regulation of blood nitric oxide (NO) levels is an essential component of maintaining ..." | ||
| Vol 2, No 2 (2010) | Moderate cognitive disorders as a multidisciplinary problem | Abstract similar documents |
| V. V. Zakharov | ||
| "... Указано, что умеренные когнитивные нарушения (УКН) представляют собой приобретенное снижение одной ..." | ||
| Vol 5, No 1 (2013) | Clinical value of the major types of reactions of the body’s stress-regulating systems in ischemic stroke | Abstract similar documents |
| Aleksandr Mikhailovich Dolgov, A Yu Ryabchenko | ||
| Vol 4, No 2 (2012) | Evolution of cognitive deficit: mild and moderate cognitive impairments | Abstract similar documents |
| V V Zakharov | ||
| "... легкие (ЛКН), так и умеренные (УКН), не вызывающие профессиональной и социально-бытовой дезадаптации ..." | ||
| Vol 6, No 2 (2014) | Voxel-based moprhometry in the differential diagnosis of posttraumatic cognitive impairments | Abstract similar documents |
| M.M. Odinak, S.V. Vorobyev, V.А. Fokin, A.Yu. Emelin, V.Yu. Lobzin, A.V. Sokolov | ||
| "... . Во 2-ю группу вошли 22 пациента с легкими (ЛКН) и умеренными (УКН) КН, с повторной легкой ЧМТ в ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... synthase of nitric oxide, nitric oxide, peroxynitrite, and nitrate. Neuroprotective approaches aimed ..." | ||
| Vol 6, No 3 (2014) | Cognitive impairments in clinical practice and analyzing the work of a memory room in Yaroslavl (an outpatient reception) | Abstract similar documents |
| N. V. Pizova, M. V. Danilova | ||
| "... жизни. У 20 пациентов (13 женщин и 7 мужчин) с УКН сосудистого генеза в возрасте от 45 до 59 лет (в ..." | ||
| Vol 17, No 1 (2025) | Analysis of the migraine characteristics in the perimenopause | Abstract similar documents |
| D. A. Klimentova, G. R. Tabeeva | ||
| "... of days with headache per month are significantly higher in perimenopause than in RA (p<0.05). The risk ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... in scores on the HAMD-17 scale was noted in the remission group from the 7th day of agomelatine therapy (p<0.05 ..." | ||
| Vol 12, No 2 (2020) | Quality of life indicators in assessing the results of various surgical treatment methods for cervical myelopathy | Abstract similar documents |
| A. A. Chekhonatsky, N. E. Komleva, V. N. Nikolenko, V. A. Chekhonatsky | ||
| "... .7±2.1 to 49.6±3.1 arbitrary units (arb. unit) (p<0.05) and in role physical functioning from 39.4±2 ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... ) 29.2–34.1; α<0.05); the disease duration was 4.69 months (CI 3.31–6.08; α<0.05); the EDSS scores ..." | ||
| Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
| S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
| "... muscle tone according to the Ashworth scale (p<0.05), which was recorded at all visits as compared ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... scores (p<0.05), lower MFI (p<0.05), and Spielberger-Hanin test scores (p<0.05) compared to the control ..." | ||
| Vol 13, No 6 (2021) | The effect of sleep duration on the risk of diabetes mellitus in an open population of men aged 45–64 years (international epidemiological studies) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, L. V. Shcherbakova, A. N. Tripelgorn, S. K. Malyutina, O. D. Rymar, S. V. Mustafina, I. V. Gagulin, A. V. Gafarova | ||
| "... , 7-hour sleep prevailed – 39.2%, 6- and 8-hour sleep – 25.3% each (÷2=7.774; df=5; p>0.05). In men ..." | ||
| Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
| V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
| "... there was an increase in the severity of anxiety up to 9.93±4.7 points (in the control group – 4.28±3.5 points; p≤0.05 ..." | ||
| Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
| O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
| "... with subclinical depression (n=116): CRP – 2.03 mg/l, МСР-1 – 0.66 ng/ml (р<0.05). Correlation analysis showed ..." | ||
| Vol 3, No 4 (2011) | Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease | Abstract similar documents |
| M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev | ||
| "... than in those with mixed and left IPFIAs (p<0.05). Left-sided PD onset was significantly more common ..." | ||
| Vol 14, No 4 (2022) | Effect of statins on oxidative stress and cognitive function in patients with cerebral atherosclerosis: results of a prospective cohort study | Abstract similar documents |
| K. V. Nikulina, O. V. Vorobieva, V. V. Fateeva | ||
| "... as a significant increase in attention- (by 1.5 points versus 0.1 points; p<0.05) and memory- (by 0.9 points ..." | ||
| Vol 14, No 6 (2022) | Features of pathogenesis and risk factors of in-hospital ischemic stroke | Abstract similar documents |
| S. V. Kolomentsev, N. V. Tsygan, I. A. Voznyuk, S. N. Yanishevskiy, E. I. Shermatyuk, O. M. Ilyina, I. V. Litvinenko | ||
| "... of strokes of another established etiology was 24.8% and was higher than in therapeutic (9.8%; p<0.05 ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... and discussion. After 3 months, only the piribedil group showed a significant neuropsychological improvement (p<0.05 ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Specific features of epilepsy in children with brain tumors | Abstract similar documents |
| G. V. Kalmykova, A. F. Neretina, Zh. Yu. Chefranova | ||
| "... epilepticus in 9% of the patients. Different types of generalized seizures were more common (53%; p≥0.05 ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Analysis of migraine characteristics in postmenopausal women | Abstract similar documents |
| D. A. Klimentova, O. V. Kosivtsova, A. V. Sergeev, G. R. Tabeeva | ||
| "... in patients in the PM than in patients in the RP [p<0.05; relative risk (RR) 1.77]. The risk of necessity ..." | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... IIIarterialhyper-tension (46.2% vs. 17.9% in group 2; p<0.05), had a history of ischemic stroke (38.5% vs. 5 ..." | ||
| Vol 15, No 3 (2023) | Prediction of restoration of swallowing function in patients with ischemic stroke and neurogenic dysphagia | Abstract similar documents |
| A. A. Borzdyko, V. I. Ershov, N. V. Gumalatova, T. Yu. Lozinskaya, E. D. Lutsai | ||
| "... in severity (p<0.05). In the cardioembolic subtype of IS, the probability of switching patients to self ..." | ||
| Vol 14, No 2 (2022) | Cognitive functions and professional status in the open population of Russia/Siberia among adults aged 25–44 years | Abstract PDF (Eng) similar documents |
| A. V. Sukhanov, M. I. Voevoda, E. A. Gromova, D. V. Denisova, V. V. Gafarov | ||
| "... words it reached 0.735 words, and in delayed recall – 1.096 words (p<0.05). Attention assessment using ..." | ||
| Vol 15, No 1 (2023) | Association of sleep disorders with various polymorphic variants of the 5-HTTLPR SNP rs25531 A>G gene in people aged 25–44 | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, M. A. Gubina, A. V. Gafarova | ||
| "... =11.397; df=4; p<0.05). In 19.6% of men and 21.5% of women, sleep duration was 6 hours per day, 5 ..." | ||
| Vol 11, No 3 (2019) | Secondary hypokalemic myoplegias | Abstract similar documents |
| T. G. Sakovets, E. I. Bogdanov | ||
| "... etiology, there were shorter (5.8±4-day) muscle weakness episodes (p<0.05). The SHM duration was recorded ..." | ||
| Vol 15, No 3 (2023) | Association of the circadian rhythm gene ARNTL/BMAL1 with personal anxiety among people aged 25–64 (WHO international program “MONICA-psychosocial (MOPSY)”) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, I. V. Gagulin, D. O. Panov, V. N. Maksimov, А. V. Gafarova | ||
| "... genotypes of the ARNTL gene was 2 times higher (p<0.05) in the general population and 2.4 times (p<0.05 ..." | ||
| Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
| E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
| "... those who did not take adamantanes (p<0.05). At the same time, there were no significant differences ..." | ||
| Vol 14, No 3 (2022) | The efficacy of ipidacrine in patients with diabetic polyneuropathy | Abstract similar documents |
| P. R. Kamchatnov, E. R. Barantsevich, A. V. Chugunov, A. A. Kabanov, B. A. Abusueva | ||
| "... group, the total scores on the NSS scale decreased by 37% (p<0.05) by the 60th day of treatment ..." | ||
| Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
| V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
| "... 2.92 [0; 6.7] to 1.95 [0; 3.07] (p<0.05). LCM demonstrated a high efficacy and a good tolerance ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... pressure level (p<0.05) and AH duration (p<0,05) were significantly associated with the severity of each ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Carpal tunnel syndrome: issues of diagnosis and treatment | Abstract similar documents |
| A. S. Gilveg, V. A. Parfenov, G. Yu. Evzikov | ||
| "... .24±0.41 at 1 and 12 months, respectively (p<0.05), the mean functional state score dropped from 2.92±0 ..." | ||
| Vol 11, No 3 (2019) | Posthypoxic encephalopathy in patients undergoing coronary artery bypass surgery: clinical, neuropsychological, and neuroimaging aspects | Abstract similar documents |
| O. A. Portik, Yu. N. Tsarevskaya, A. Yu. Efimtsev, T. M. Alekseeva, G. E. Trufanov | ||
| "... . Posthypoxic encephalopathy was diagnosed in 10 and 67% of patients in Group 1 and 2, respectively (p=0.05 ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... , a statistically significant improvement (p<0.05) was observed in group 1: reduction in headache frequency ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... – 3.6%, χ2 =24.142, df=8, p<0.01 and women – 3.7%, χ2 =15.538, df=8, p<0.05) only some heart diseases ..." | ||
| Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
| "... .8%) and effective AD in all groups. Also, escitalopram, vortioxetine, and venlafaxine (p˂0.05) showed high efficacy ..." | ||
| Vol 13, No 5 (2021) | Insomnia in chronic non-specific low back pain | Abstract similar documents |
| I. A. Lamkova, V. A. Parfenov | ||
| "... (p<0.05). Sleep quality between 7th and 90th days significantly improved only in the extended therapy ..." | ||
| Vol 10, No 3 (2018) | The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect | Abstract similar documents |
| S. P. Sergeeva, А. А. Savin, I. D. Breslavich, P. F. Litvitsky, V. V. Arkhipov | ||
| "... : hypercholesterolemia of days 1, 7 (p<0.01) and 21 (p<0.05), hypertension in day 1 (p<0.05), diabetes mellitus on days 1 ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... groups did not differ (p ≥ 0.05) in parameters such as pain intensity according to VAS (6.65 ± 1.93 and 6 ..." | ||
| Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
| A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
| "... (Cresp, C30:15, and CVals) in MS patients (p<0.05). The isometric contraction test showed a statistically ..." | ||
| Vol 4, No 2 (2012) | Secondary prevention of ischemic stroke: from recommendations to real clinical practice | Abstract similar documents |
| V A Shandalin, A V Fonyakin, L A Geraskina | ||
| "... with antithrombotic agents, indirect anticoagulants in particular (p < 0.05). ..." | ||
| Vol 4, No 2 (2012) | Influence of a complex of muscle-strengthening exercises on quality of life in lumbosacral pain | Abstract similar documents |
| I A Zaitseva | ||
| "... ascertained to be diminished statistically significantly (p <0.05). Conclusion. The developed procedure ..." | ||
| Vol 14, No 5 (2022) | The relationship between dissociative experiences and childhood trauma in nursing and midwifery students | Abstract PDF (Eng) similar documents |
| F. F. Arabpour, Sh. Amini, R. Bidaki, R. Ashtari, F. Sepehri, A. Moghadam Ahmadi, H. Bakhshi, B. Bozorg | ||
| "... and dissociative experiences score (P<0.05). Conclusion. The prevalence of dissociative experiences among ..." | ||
| Vol 15, No 2 (2023) | Readiness potential as a neurophysiological marker of functional movement disorders | Abstract PDF (Eng) similar documents |
| V. A. Tolmacheva, E. N. Dudnik, R. M. Shishorin, D. S. Petelin, V. E. Bezrukov, A. N. Gamirova, Yu. V. Dolgopolova, B. A. Volel | ||
| "... .69 ms versus 276.28±176.1 ms (p<0.05), and its amplitude: -0.85±0.294 μV versus -0.35±0.26 μV (p<0.05 ..." | ||
| Vol 15, No 2 (2023) | Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis | Abstract similar documents |
| I. A. Gribacheva, T. F. Popova, E. V. Petrova, A. V. Zvonkova | ||
| "... and with the comparison group (p<0.05). The use of Mexidol was accompanied by a decrease in the severity of complaints ..." | ||
| 1 - 70 of 155 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
